Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Operating Expenses: 2023-2025

Historic Operating Expenses for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to $52.8 million.

  • CG Oncology's Operating Expenses rose 86.30% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.3 million, marking a year-over-year increase of 88.60%. This contributed to the annual value of $115.8 million for FY2024, which is 108.08% up from last year.
  • As of Q3 2025, CG Oncology's Operating Expenses stood at $52.8 million, which was up 8.32% from $48.7 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Operating Expenses ranged from a high of $52.8 million in Q3 2025 and a low of $9.9 million during Q1 2023.
  • Moreover, its 3-year median value for Operating Expenses was $26.0 million (2024), whereas its average is $28.7 million.
  • Data for CG Oncology's Operating Expenses shows a peak YoY surged of 131.95% (in 2024) over the last 5 years.
  • CG Oncology's Operating Expenses (Quarterly) stood at $19.4 million in 2023, then skyrocketed by 98.93% to $38.5 million in 2024, then soared by 86.30% to $52.8 million in 2025.
  • Its last three reported values are $52.8 million in Q3 2025, $48.7 million for Q2 2025, and $42.3 million during Q1 2025.